Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: Feasibility study

Radiology

Volumn 246, Issue 3, 2008, Pages 734-741

  Sevick Muraca, Eva M ^a   Sharma, Ruchi ^a   Rasmussen, John C ^a   Marshall, Milton V ^a   Wendt, Juliet A ^a   Pham, Hoang Q ^a   Bonefas, Elizabeth ^a   Houston, Jessica P ^a   Sampath, Lakshmi ^a   Adams, Kristen E ^a   Blanchard, Darlene Kay ^a   Fisher, Ronald E ^a   Chiang, Stephen B ^b   Elledge, Richard ^a   Mawad, Michel E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; DIAGNOSTIC AGENT; FLUORESCENT DYE;

ADULT; AGED; ARTICLE; AXILLA; BREAST; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; DRUG DOSE ESCALATION; FEASIBILITY STUDY; FEMALE; FLUORESCENCE; HUMAN; INFORMED CONSENT; LYMPH FLOW; LYMPH NODE; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; NEAR INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIOACTIVITY; SENTINEL LYMPH NODE; STERNUM; BREAST TUMOR; CANCER STAGING; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTILLATION CAMERA; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLUORESCENT DYES; GAMMA CAMERAS; HUMANS; INDOCYANINE GREEN; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; STERNUM;

EID: 40949113163     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2463070962     Document Type: Article

References (19)

1. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941-946.
2. Querzoli P, Pedriali M, Rinaldi R, et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 2006;12:6696-6701.
3. Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG, McGuckin MA. Occult axillary lymph node metastases in breast cancer do matter results of 10-year survival analysis. Am J Surg Pathol 2002;26:1286-1295.
4. Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997;4:447-451.
5. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymphnode metastases in management of breast cancer. Lancet 1999;354:896-900.
6. Adams KE, Ke S, Kwon S, et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt 2007;12:(2)024017.
7. U.S. Department of Health and Human Services, Center for Drug Evaluation and Research. Guidance for industry, investigators, and reviewers exploratory IND studies. Rockville, Md: U.S. Department of Health and Human Services, 2006.
8. Reynolds JS, Troy TL, Sevick-Muraca EM. Multipixel techniques for frequency-domain photon migration imaging. Biotechnol Prog 1997;13:669-680.
9. Glantz SA. Primer of biostatistics. New York, NY: McGraw-Hill, 2005.
10. Sharma R, Wang W, Rasmussen JC, et al. Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol 2007;292:H3109-H3118.
11. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanin green dye in breast cancer patients. Jpn J Clin Oncol 1999;29:604-607.
12. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 2005;12:211-215.
13. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-2566.
14. Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R. Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol 2000;35:479-485.
15. Wu Y, Cai W, Chen X. Near-infrared fluorescence imaging of tumor integrin alpha(v)beta(3) expression with Cy7-labeled RGD multimers. Mol Imaging Biol 2006;8:226-236.
16. Li C, Wang W, Wu QP, et al. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol 2006;33:349-358.
17. Hwang K, Houston JP, Rasmussen JC, Ke S, Li C, Sevick-Muraca EM. Enhanced fluorescence optical imaging with improved excitation light rejection. J Mol Imaging 2005;4:194-204.
18. Joshi A, Bangerth W, Sevick-Muraca EM. Adaptive finite element based tomography for fluorescence optical imaging in tissue. Opt Express 2004;12:5402-5417.
19. Rusznyak I, Foldi M, Szabo G. Lymphatics and lymph circulation. London, England: Pergamon, 1967.